Patient Characteristics | N = 42 |
---|---|
Overall median follow up period (months, range) | 28.7 (8.4-49.1) |
Age (years, mean ± SD) | 60.1 ± 10.9 |
Sex (male/female) | 32/10 |
Cause of HCC (HBV/HCV/Alcohol/Others) | 29/7/2/4 |
ECOG performance (0/1) | 41/1 |
Child-Pugh classification (A/B/C) | 38/4/0 |
AJCC stage (I/II/IIIa/IV) | 23/16/3/0 |
Median tumor volume (cc, range) | 15.4 (3.04-81.82) |
Tumor number (solitary/multifocal) | 27/15 |
Initial median AFP (ng/dl, range) | 13.9 (1.0-798.8) |
Previous therapy | |
No treatment | 8 |
TACE alone | 16 |
TACE combined with locoregional therapies | 16 (PEI 13, RFA 3) |
TACE combined with surgical resection | 2 |